Pharmaceuticals
Healthcare
US FDA finds Sun Pharma's response to import ban inadequate
US drug regulator has said that Sun Pharma’s response to the ban on imports of products made at one of ......
Healthcare
Mires puts total fair valuation of Dr Datsons at $60M
European pharma player Mires B.V has completed its valuation exercise as part of its interest to acquire majority stake in ......
Healthcare
AstraZeneca rejects Pfizer's final offer worth $118B
British drug maker AstraZeneca has rejected the fourth and final takeover offer worth $118 billion by Pfizer Inc on Monday ......
Healthcare
US-based Cancer Genetics acquires Ventureast-backed BioServe India
US-based Cancer Genetics Inc (CGI), a NASDAQ-listed company that provides DNA-based diagnostics, has acquired Hyderabad-based BioServe Biotechnologies (India) Pvt Ltd, ......
Healthcare
Sun Pharma settles litigation with Novartis to launch generic drug in US
Sun Pharmaceutical Industries Ltd, the country’s largest drugmaker by market capitalisation, has signed a settlement agreement with international drug major ......
Healthcare
Shasun Pharma strengthening its drug formulation business
Chennai-based contract research and manufacturing company Shasun Pharmaceuticals Ltd is building up its formulation business so that it could contribute ......
Healthcare
Torrent group to split responsibilities between two promoter brothers
Torrent Pharmaceuticals Ltd, the flagship company of Ahmadabad-based Torrent group, will see a churn in its top management. Sudhir Mehta, ......
Pharmaceuticals
Licensing income can bring upsides to our target of $1B revenue by 2018: Kiran Mazumdar-Shaw of Biocon
Biocon Ltd is India’s largest biotechnology company founded by Kiran Mazumdar-Shaw in 1978. The company, which started with an initial ......
Healthcare
Bayer to buy Merck's global consumer care unit for $14.2B
Marijn Dekkers-led German pharma giant Bayer has struck a deal to acquire the consumer care business of Merck & Co., ......
Healthcare
Shasun acquires global rights for analgesic drug and brand Nuprin from ScolrPharma
Chennai-based Shasun Pharmaceuticals Ltd has acquired the global rights to develop and commercialise Ibuprofen 12-hour extended release OTC tablets as ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News